LENZ THERAPEUTICS INC

NASDAQ: LENZ (LENZ Therapeutics, Inc.)

Last update: 20 hours ago

4.59

-0.09 (-1.92%)

Previous Close 4.68
Open 4.65
Volume 497,463
Avg. Volume (3M) 864,650
Market Cap 144,219,376
Price / Sales 6.67
Price / Book 0.670
52 Weeks Range
4.54 (-1%) — 50.40 (998%)
Earnings Date 4 Nov 2026
Diluted EPS (TTM) 0.660
Total Debt/Equity (MRQ) 0.62%
Current Ratio (MRQ) 23.09
Operating Cash Flow (TTM) -51.50 M
Levered Free Cash Flow (TTM) -40.56 M
Return on Assets (TTM) -17.75%
Return on Equity (TTM) -24.47%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bullish
Biotechnology (Global) Mixed Bullish
Stock LENZ Therapeutics, Inc. Mixed Bullish

AIStockmoo Score

1.7
Analyst Consensus NA
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 5.0
Technical Oscillators -0.5
Average 1.67

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
LENZ 144 M - - 0.670
ELVN 4 B - - 4.90
BRVE 2 B - - -
NGNE 793 M - - 3.29
IMAB 534 M - - 2.42
CNTB 152 M - - 5.38

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Sector Healthcare
Industry Biotechnology
% Held by Insiders 2.76%
% Held by Institutions 92.94%

Ownership

Name Date Shares Held
Alpha Wave Global, Lp 30 Jun 2026 3,612,211
Versant Venture Management, Llc 30 Jun 2026 2,656,888
72 Investment Holdings, Llc 30 Jun 2026 1,017,751
C Worldwide Group Holding A/S 30 Jun 2026 700,000

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria